BioSpace News Archive

Aphios International announces the launch of a crowdfunding campaign, Virus-Free Blood: Our Best Defense for Fighting Disease (https://tinyurl.com/y4fojsb3

The Voluntary Escrow serves further validates investors belief and support of Havn Life’s business plan and future growth strategy

The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, recently announced the launch of its BE Safe @Home project to bring surveillance for recurrence of non-muscle invasive bladder cancer (NMIBC) to patients’ homes with its Bladder EpiCheck® urine test

Tenzing Acquisition Corp., a special purpose acquisition company incorporated in the British Virgin Islands (“Tenzing”) (NASDAQ: TZAC), and Reviva Pharmaceuticals, Inc., a Delaware corporation (“Reviva”) and a California-based clinical-stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases,

Thermo Fisher Scientific, the world leader in serving science, today announced the new Thermo Scientific Tundra Cryo Transmission Electron Microscope (Cryo-TEM), a groundbreaking instrument that extends cryo-electron microscopy (cryo-EM) to more scientists by delivering industry-leading ease of use at an affordable price.

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the recent publication by Practical Pain Management of a commentary discussing the benefits of using DSUVIA for acute pain management.

Cognoptix, a leading diagnostics company dedicated to early detection of Alzheimer’s disease (AD), announced today the formation of its new Scientific Advisory Board (SAB) with appointment of five world-class scientists and clinical researchers in AD. The SAB includes Jeffrey L. Cummings , MD, ScD; Lee E. Goldstein , MD, PhD

Cerner Corporation (NASDAQ: CERN) announced today that Major General Elder Granger, M.D., U.S. Army (retired) has been appointed to the company’s Board of Directors, effective Nov. 16, 2020. Dr. Granger, 67, is president and chief executive officer of The 5Ps, LLC, a health care, education and leadership consulting organization. “It’s an honor to welcome Dr. Granger to our Board,” said Brent Shafer, Cerner’s chairman and chief executive o

2020 has been a year of uncertainty, and among those most affected are non-profit organizations and kids with cancer.